Oxytocin stimulated release of PGF2α and its inhibition by a cyclooxygenase inhibitor and an oxytocin receptor antagonist from equine endometrial cultures.

The research article investigates how oxytocin affects horse uterine tissue and the potential use of inhibitors to reduce the production of a compound that leads to uterine inflammation and early embryonic loss.

Objective of the Research

• The research aimed to understand the role of oxytocin in stimulating the production of prostaglandin F2α (PGF2α) in horse uterine tissue, and the effects of inhibitors, Atosiban (oxytocin receptor antagonist) and indomethacin (a cyclooxygenase inhibitor), in reducing this production.

Methodology

• The researchers used equine endometrial explants (samples of horse uterine tissue) taken on the second day of behavioral estrus (part of the mare’s reproductive cycle).
• These tissue samples were then exposed to oxytocin to stimulate the production of PGF2α and their concentrations over time were measured.
• Further experiments were carried out on these samples, in which they were cultured with Atosiban and indomethacin for 6 hours, to see how these inhibitors affected PGF2α secretion.

Findings

• In the presence of oxytocin, PGF2α concentrations were significantly higher in each time point over a 24-hour culture period compared to controls.
• Oxytocin did not elicit PGF2α release in samples cultured with either Atosiban or indomethacin, revealing that these inhibitors were effective in curbing the production of PGF2α.

Implications of the Study

• These findings suggest that the secretion of PGF2α in response to oxytocin is an event mediated by an oxytocin receptor that activates the prostaglandin synthesis cascade through cyclooxygenase.
• The study provides a foundation for potential in vivo applications of these inhibitors to reduce horse uterine PGF2α secretion. Lowering this secretion may prevent early embryonic loss, an issue that could have significant implications for the equine breeding industry.